Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines
Inderjit Jabbal‐Gill(University of Nottingham), Allen G.A. Coombes(Queen's Medical Centre), Ed C. Lavelle(Trinity College Dublin), Lin Wu(Fujian Agriculture and Forestry University), John Wood(Women's and Children's Hospital), Xiongwei Li(Huazhong University of Science and Technology), Paul Jenkins, Monica Jimenez, Peter Watts, Diane Major(National Institute for Biological Standards and Control), Philip D. Minor(National Institute for Biological Standards and Control), Stanley S. Davis, Lisbeth Illum(Critical Pharmaceuticals (United Kingdom))
Cited by 47
Related Papers
A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis
|The Journal of Experimental Medicine|2006|991
Mucosal vaccines — fortifying the frontiers
|Nature reviews. Immunology|2021|724
Location and primary structure of a major antigenic site for poliovirus neutralization
|Nature|1983|194
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
|Nature Communications|2021|176
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection
|PLoS Pathogens|2015|164